Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CISAPRIDE Cause Electrocardiogram qt prolonged? 215 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 215 reports of Electrocardiogram qt prolonged have been filed in association with CISAPRIDE. This represents 47.2% of all adverse event reports for CISAPRIDE.

215
Reports of Electrocardiogram qt prolonged with CISAPRIDE
47.2%
of all CISAPRIDE reports
1
Deaths
26
Hospitalizations

How Dangerous Is Electrocardiogram qt prolonged From CISAPRIDE?

Of the 215 reports, 1 (0.5%) resulted in death, 26 (12.1%) required hospitalization, and 24 (11.2%) were considered life-threatening.

Is Electrocardiogram qt prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CISAPRIDE. However, 215 reports have been filed with the FAERS database.

What Other Side Effects Does CISAPRIDE Cause?

Death (15) Atrial fibrillation (13) Pneumonia (13) Drug hypersensitivity (12) Exposure during pregnancy (11) Nausea (11) Abortion spontaneous (10) Respiratory distress (10) Abdominal pain (9) Vomiting (9)

What Other Drugs Cause Electrocardiogram qt prolonged?

QUETIAPINE (1,869) OLANZAPINE (1,325) RIBOCICLIB (1,020) AMIODARONE (1,000) HYDROXYCHLOROQUINE (992) CLOZAPINE (958) CITALOPRAM HYDROBROMIDE (917) ESCITALOPRAM OXALATE (899) ONDANSETRON (881) BUPROPION (853)

Which CISAPRIDE Alternatives Have Lower Electrocardiogram qt prolonged Risk?

CISAPRIDE vs CISATRACURIUM CISAPRIDE vs CISPLATIN CISAPRIDE vs CISPLATIN\CYTARABINE\DEXAMETHASONE CISAPRIDE vs CITALOPRAM CISAPRIDE vs CITALOPRAM HYDROBROMIDE

Related Pages

CISAPRIDE Full Profile All Electrocardiogram qt prolonged Reports All Drugs Causing Electrocardiogram qt prolonged CISAPRIDE Demographics